[Federal Register Volume 86, Number 9 (Thursday, January 14, 2021)]
[Notices]
[Page 3212]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00610]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice: 21-001]


Notice of Intent To Grant a Partially Exclusive Patent License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of intent to grant a partially exclusive patent license.

-----------------------------------------------------------------------

SUMMARY: NASA hereby gives notice of its intent to grant an exclusive, 
co-exclusive or partially exclusive patent license in the United States 
of America to practice the invention(s) described and claimed in U.S 
Patent No. 9,023,642 B2, Method and Apparatus for a Miniature 
Bioreactor System for Long-Term Cell Culture to Brand Labs USA, LLC, 
having its principal place of business in Pompano Beach, Florida. The 
fields of use may be limited. NASA has not yet made a determination to 
grant the requested license and may deny the requested license even if 
no objections are submitted within the comment period.

DATES: The prospective exclusive may be granted unless NASA receives 
written objections including evidence and argument, no later than 
January 29, 2021 that establish that the grant of the license would not 
be consistent with the requirements regarding the licensing of 
federally owned inventions as set forth in the Bayh-Dole Act and 
implementing regulations. Competing applications completed and received 
by NASA no later than January 29, 2021 will also be treated as 
objections to the grant of the contemplated exclusive, co-exclusive or 
partially exclusive license. Objections submitted in response to this 
notice will not be made available to the public for inspection and, to 
the extent permitted by law, will not be released under the Freedom of 
Information Act.

ADDRESSES: Objections relating to the prospective license may be 
submitted to Patent Counsel, Office of Chief Counsel, MS AL, NASA 
Johnson Space Center, 2101 NASA Parkway, Houston, TX 77058. Phone (281) 
483-4871. Facsimile (281) 483-6936. Email: <a href="/cdn-cgi/l/email-protection#83e9f0e0aef3e2f7e6edf7ece5c3eee2eaefadede2f0e2ade4ecf5"><span class="__cf_email__" data-cfemail="422831216f322336272c362d24022f232b2e6c2c2331236c252d34">[email protected]</span></a>.

FOR FURTHER INFORMATION CONTACT: Mr. Walter Ugalde, Technology Transfer 
and Commercialization Office/XT1, Johnson Space Center, Houston, TX 
77058, (281) 483-8615.

SUPPLEMENTARY INFORMATION: This notice of intent to grant an exclusive, 
co-exclusive or partially exclusive patent license is issued in 
accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). The patent 
rights in these inventions have been assigned to the United States of 
America as represented by the Administrator of the National Aeronautics 
and Space Administration. The prospective license will comply with the 
requirements of 35 U.S.C. 209 and 37 CFR 404.7.
    Information about other NASA inventions available for licensing can 
be found online at http://technology.nasa.gov.

Helen M. Galus,
Agency Counsel for Intellectual Property.
[FR Doc. 2021-00610 Filed 1-13-21; 8:45 am]
BILLING CODE 7510-13-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>